HOME >> BIOLOGY >> NEWS
New research suggests therapeutic approach for autoimmune diseases

BAR HARBOR, ME Researchers at The Jackson Laboratory have identified a novel therapeutic target for treating autoimmune disease.

In research published in the May Journal of Clinical Investigation, a team headed by Senior Staff Scientist Derry Roopenian discovered that a normally functioning protein, referred to as FcRn, plays an important role in promoting arthritis, a common form of autoimmune disease.

In total, 80 known autoimmune diseases strike 10 million Americans, and constitute one of the leading causes of disability among women. Women comprise 75 percent of patients with autoimmune disease.

The immune system, composed of white blood cells, provides the major line of defense against infectious microorganisms. Plasma cells are white blood cells that secrete proteins called antibodies. These antibodies normally circulate throughout the body, looking for infectious organisms. The antibodies attach to the microorganisms and promote their destruction.

However, in some individuals, too many antibodies are produced, and many of them can "go bad" in that they attach to normal tissues rather than the foreign invaders. These antibodies are referred to as autoantibodies, and they are thought to promote many forms of autoimmune diseases, including lupus, rheumatoid arthritis, myasthenia gravis, immune thrombocytopenic purpura (ITP) and autoimmune thyroiditis, to name a few. So, Dr. Roopenian and his colleagues sought to devise methods to reduce the number of autoantibodies available for tissue destruction.

The research team focused on FcRn, whose normal job is to preserve antibodies in the circulation. "While a good thing in normal individuals, FcRn could be working too efficiently in patients with lupus and rheumatoid arthritis," explains Dr. Roopenian. "The consequence is the maintenance of dangerously high levels of autoantibodies."

To test this idea, Dr. Roopenian used mice that normally develop arthritis caused
'"/>

Contact: Joyce Peterson
joyce@jax.org
207-288-6058
Jackson Laboratory
3-May-2004


Page: 1 2

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
3. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
4. Belgian researchers explore revolutionary approach to angiogenesis
5. Award winning researchers reveal potential new role for Glivec
6. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
7. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
8. Gene chips research in cotton could lead to superior variety
9. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
10. New hydrothermal vents discovered as South Pacific Odyssey research begins
11. University of Alberta researcher looks for clues to mysterious disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2019)... ... February 12, 2019 , ... Ava, a 115-pound Newfoundland, ... partially tore one of her cruciate ligaments. Just one year later, she suffered ... was able to recover without surgical intervention and resumed her normal activities without any ...
(Date:2/11/2019)... WASHINGTON (PRWEB) , ... February 11, 2019 , ... ... an Allotrope™ Data Model (ADM), completing the phased release of the Allotrope™ Framework ... new capability combines with the previously released Allotrope™ Data Format (ADF) and application ...
(Date:2/2/2019)... ... January 31, 2019 , ... Pharmica Consulting announced it will ... and focusing on all facets of clinical trial planning and management. Pharmica ... management, patient engagement, and more. , “We have attended the SCOPE Summit ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... ... January 22, 2019 , ... Dr. Douglas Stramel of ... Pall Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly three years. A ... Cell Therapy since 2007 and began using V-PET™ 2016. V-PET™ is a ...
(Date:1/20/2019)... ... January 17, 2019 , ... Consumers are directing healthcare ... of physicians. That's changing as many services now exist for patients to order ... market totaled $208 million in 2018, according to Kalorama Information’s new report, ...
(Date:1/15/2019)... ... January 15, 2019 , ... With the U.S. Congress designating January as Cervical Health ... testing service, today announces tips to help reduce the risk of Cervical Cancer. , ... Genital HPV is the #1 most common STD and an STI that almost ...
(Date:1/10/2019)... ... ... VGI Medical was founded in 2007 based on an invention developed by Tov ... VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are specifically designed to ... to limit motion of the affected spinal segment. Applying the principles of this success, ...
Breaking Biology Technology:
Cached News: